Pattern of Use and Long-Term Safety of Tyrosine Kinase Inhibitors: A Decade of Real-World Management of Chronic Myeloid Leukemia Alessandra Bettiol,Ettore Marconi, Niccolò Lombardi, Giada Crescioli, Filippo Gherlinzoni, Thomas Walley, Alfredo Vannacci, Alessandro Chinellato, Pietro Giusti Background and Objectives First-line treatment of chronic phase (CP) chronic myeloid leukemia (CML) is based on the first-generation tyrosine kinase inhibitor (TKI) imatinib…
Stillbirth and perinatal care: Are professionals trained to address parents’ needs? Ravaldi C, Levi M, Angeli E, Romeo G, Biffino M, Bonaiuti R, Vannacci A. Midwifery. 2018 Sep;64:53-59. doi: 10.1016/j.midw.2018.05.008. Epub 2018 Jun 7. OBJECTIVE: To assess current practices of health care providers (HCPs) caring for women experiencing a stillbirth and to explore their needs for training to better…
Dovrebbe essere un momento di gioia. Eppure anche il parto può trasformarsi in un’esperienza da dimenticare. O peggio, in un trauma che segna profondamente la vita di una donna. Colpa della cosiddetta violenza ostetrica: trattamenti irrispettosi, procedure mediche imposte senza adeguate informazioni o in barba ai desideri della partoriente, abusi, maleducazione e mancanza di sensibilità , tutti pericoli che possono traumatizzare…
The use of complementary and alternative medicines during breastfeeding: results from the Herbal supplements in Breastfeeding InvesTigation (HaBIT) study. Bettiol A, Lombardi N, Marconi E, Crescioli G, Bonaiuti R, Maggini V, Gallo E, Mugelli A, Firenzuoli F, Ravaldi C, Vannacci A AIMS: The use of complementary and alternative medicines (CAMs) during breastfeeding is increasing, mainly because of their presumed greater safety compared with conventional medications. However, CAMs can cause serious…
BACKGROUND: Inter-patient variability in response to opioids is well known but a comprehensive definition of its pathophysiological mechanism is still lacking and, more importantly, no studies have focused on children. The STOP Pain project aimed to evaluate the risk factors that contribute to clinical response and adverse drug reactions to opioids by means of a systematic review and a clinical…